Here is a review of glucagon-like peptide-1 receptor agonist use in people with HIV.
|Videos|October 10, 2019
What to Expect in October's HIV/AIDS Section of Contagion®
Author(s)Contagion® Editorial Staff
Jason Schafer, PharmD, MPH, BCPS AQ-ID, previews the October issue featuring an article on rapid initiation of antiretroviral therapy.
Advertisement
Segment Description: Jason Schafer, PharmD, MPH, BCPS AQ-ID, associate professor in the Department of Pharmacy Practice at Jefferson College of Pharmacy at Thomas Jefferson University, and content editor of the HIV/AIDS section of Contagion®, previews the October issue featuring an article on rapid initiation of antiretroviral therapy.
Interview transcript: (modified slightly for readability)
Dr. Schafer: In the October issue of Contagion®, we do have an article by Dr. Bill Short on rapid initiation of antiretroviral therapy (ART). This is a considerably important topic and [there are] a lot of emerging data available about this topic and the benefits that people can have when receiving ART perhaps more quickly than we used to administer ART in the past. And so, Dr. Short reviews all of the relevant data, goes through the pros and the cons of being able to do this practice, and, on the end, provides his recommendations in terms of what clinics really need to do to be able to start ART, or antiretroviral therapy, in a rapid fashion for patients.
Advertisement
Related to this article
Lori Handy, MD, provides guidance in these areas including presentation before rash onset, when patients should be considered for the inpatient setting, and what treatment looks like.
Jason Pogue, PharmD, BCPS, BCIDP, contextualizes preliminary data looking at this trial and other extended-spectrum beta-lactamase (ESBL) studies, which reopens the debate around carbapenem-sparing treatment options.
With a significant increase in rabies exposures this year, Rodney Rohde, PhD, talks about seeking medical attention after animal interactions as well as clinical treatment when people have been bit or scratched.
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
New gyrA testing guides ciprofloxacin use for gonorrhea, cutting ceftriaxone reliance while tackling resistance, access, and FDA hurdles.
Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Advertisement
Advertisement
Trending on Contagion Live
1
Clinical Considerations for Measles: Presentation, Treatment, and Hospitalization
2
FAQ: Rising Rabies Exposure Calls PEP Decisions Back in Focus
3
Measles Update: October 2, 2026
4
Clesrovimab Given in 1st and 2nd RSV Seasons for At-Risk Infants
5